Newbridge Financial Services Group’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,500
Closed -$15.9K 1111
2024
Q1
$15.9K Hold
1,500
0.01% 654
2023
Q4
$18K Hold
1,500
0.01% 614
2023
Q3
$10.5K Hold
1,500
0.01% 811
2023
Q2
$12.8K Buy
+1,500
New +$12.5K 0.01% 833
2021
Q1
Sell
-87
Closed -$6K 1387
2020
Q4
$6K Hold
87
﹤0.01% 811
2020
Q3
$3K Buy
+87
New +$2.94K ﹤0.01% 866

Other funds holding CDNA

Newbridge Financial Services Group's CDNA Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of CareDx (CDNA) in Q2 2024, closing a stake of 1,500 shares — an estimated $15.9K sold.

Newbridge Financial Services Group first reported a position in CDNA in Q3 2020 and held it in 6 quarters. The position peaked at $18K in Q4 2023. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining CareDx position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 1,500 CareDx shares in Q2 2024, an estimated $15.9K.
  • Newbridge Financial Services Group first reported a position in CareDx in Q3 2020 and held it in 6 quarters.
  • Newbridge Financial Services Group's CareDx position peaked at $18K in Q4 2023.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.